Camcevi Европейски съюз - български - EMA (European Medicines Agency)

camcevi

accord healthcare s.l.u. - leuprorelin mesilate - Простатни неоплазми - Ендокринна терапия - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Thalidomide Lipomed Европейски съюз - български - EMA (European Medicines Agency)

thalidomide lipomed

lipomed gmbh - Талидомид - Множествена миелома - Имуносупресори - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.